Skip to content

Clinical Trial for the Behavioral and Imaging Study of Fu Fang Dan Hong Injection Intervenes in Stroke

Clinical Trial for the Behavioral and Imaging Study of Fu Fang Dan Hong Injection Intervenes in Stroke

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15005807
Enrollment
Unknown
Registered
2015-01-02
Start date
2015-01-13
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

A:Conventional western medicine treatment and Fu Fang Dan Hong Injection
B:Conventional western medicine treatment

Sponsors

Centre for Beijing Aging Brain Rejuvenation initiative.Beijing Normal University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: Both the following 4 items are required: 1. In accordance with western medicine diagnosis of cerebral infarction; 2. Disease within a week; 3. NIHSS score more than 3 and less than 10; 4. Aged between 35 to 80; 5. MRI evidence cerebrovascular disease; 6. The patient or the legal representative signed the informed consent.

Exclusion criteria

Exclusion criteria: Subjects will be excluded when complied any of the item following: 1. Transient ischemic attack (TIA); 2. Cerebral hemorrhage or subarachnoid hemorrhage; 3. Check confirmed that the stroke was caused by brain tumors, brain trauma and blood diseases; 4. Cerebral embolism caused by atrial fibrillation with rheumatic heart disease, coronary heart disease or any other heart diseases; 5. Bone and joint diseases and some other serious diseases which were associated with liver, kidney, hematopoietic system and endocrine system etc.; 6. Mental disorders or severe dementia; 7. Patients can not be performed with MRI which has accepted pacemaker surgery, coronary intervention surgery or coronary artery bypass surgery; 8. Patients can not be performed with MRI which has a magnetic implant inside.

Design outcomes

Primary

MeasureTime frame
The National Institutes of Health Stroke Scale;Stroke Specific Quality of Life Scale;

Secondary

MeasureTime frame
Barthel Index;modified Rankin Scale;Mini-Mental State Examination;Montreal Cognitive Assessment;Pittsburgh Sleep Quality Index;Blood lipid detecting various indicators;

Countries

China

Contacts

Public ContactZHANG Zhan-Jun
zhang_rzs@bnu.edu.cn+86 010 58802005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026